Artificial Kidney Market Size, Share & Growth Report [2031]

Artificial Kidney Market Size, Share & Growth Report [2031]

Segments - Artificial Kidney Market by Device Type (Implantable Artificial Kidney and Wearable Artificial Kidney), Dialysis (Peritoneal Dialysis, Hemodialysis, and Combination), Application (Pediatrics and Adults), End-user (Ambulatory Surgical Centers, Specialty Clinics, and Hospitals), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-5416 | 4.4 Rating | 74 Reviews | 188 Pages | Format : Docx PDF

Report Description


The artificial kidney market size was valued at USD 0.11 Bn in 2022 and is expected to reach USD 6.6 Bn by 2031, expanding at a CAGR of 60.35% during 2023–2031. The market growth is driven by the rising number of patients with kidney-related disorders, the limited supply of kidney donors, and increasing research and developments.

An artificial kidney, also known as a bioartificial kidney or renal replacement device, is a medical device designed to replicate the functions of a natural human kidney. The kidneys are essential organs liable for filtering excess fluid and waste products from the blood, maintaining electrolyte balance, and regulating blood pressure.

Artificial Kidney Market Outlook


The demand for artificial kidneys is rapidly growing due to the rising prevalence of chronic kidney disease worldwide. The major cause of chronic kidney disease is diabetes and high blood pressure, which leads to the cause of health problems such as heart disease and strokes. Kidney diseases include glomerulonephritis, IgA Nephropathy, and lupus nephritis can lead to chronic kidney disease, kidney failure, and death.

  • As per the data published by the National Institute of Diabetes and Digestive and Kidney Disease in September 2021, CKD affects more than 1 in 7 United States adults, approximately 37 million Americans. Almost 1 in 3 individuals have diabetes and 1 in 5 people with high blood pressure have a kidney disease. The adverse impact of kidney diseases leads to kidney failure and other health problems such as heart attacks or strokes.

Artificial kidneys have the potential to improve the quality of life for individuals with kidney failure. Compared to traditional dialysis, which often requires multiple sessions per week and restricts daily activities. The artificial kidney could provide a more continuous and efficient filtration process, allowing patients to have greater freedom and flexibility in their daily lives. The demand for artificial kidneys is increasing as the prevalence of chronic diseases and conditions such as end-stage renal diseases and kidney failures.

The market report finds that the COVID-19 pandemic affected the artificial kidney market. During the virus outbreak, healthcare organizations and research labs primarily focused on developing diagnostic kits, protective equipment, and treatments for the virus. This has led to a lack of attention and resources for other healthcare, including kidney-related treatments. During the pandemic, all the other operations were at a halt due to the lack of medical resources which led to hampering the artificial kidney market.

 

Artificial Kidney Market Dynamics

Artificial Kidney Market Dynamics

Major Drivers

Rising prevalence of kidney-related disorders around the world drives the artificial kidney market. According to the National Institutes of Health in March 2022, 10% of the global population is living with chronic kidney disease. This means more than 800 million individuals suffer from CKD every year.

CKD is one of the leading causes of mortality across the world owing to complications and high costs related to treatments. Ongoing R&D to develop advanced artificial kidneys is expected to boost market revenue during the forecast period.

  • For instance, The University of California San Francisco (UCSF) reported the implantable kidney project titled Kidney Project which successfully tested a prototype bioartificial kidney in September 2021. For this advance, the team won KidneyX’s Phase 1 Artificial Kidney Prize which is valued at USD 650,000. This project was developed using microchip filters and living kidney cells generated by the patient’s own heart.

Existing Restraints

Higher costs of advanced devices hamper the market. A new artificial kidney device requires to go through regulatory approval, it often undergoes extensive research, development, and clinical trials, which requires significant costs. Patients and healthcare providers may find it difficult to afford or justify the expense, especially when alternative treatment options such as dialysis are more affordable.

Emerging Opportunities

Increasing technological advancements and a growing preference for home-based care create lucrative opportunities for the market. Rapid advancements in medical technology, including nanotechnology, biotechnology, and wearable devices, present opportunities for the development of more efficient and effective artificial kidney systems. Integration of advanced technologies can lead to improved performance of devices and better treatment outcomes.

Increasing development in the production of innovative portable bio-artificial kidneys is also likely to create opportunities for the market. Newer advances are developing in the space of artificial kidneys, often similar and concerning one another. Artificial kidneys that are portable, wearable, or easily implantable can enable patients to receive continuous kidney function at home and helps to improve their quality of life. This is expected to create new pathways for the market in the coming years.

Scope of the Artificial Kidney Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Artificial Kidney Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Device Type (Implantable Artificial Kidney and Wearable Artificial Kidney), Dialysis (Peritoneal Dialysis, Hemodialysis, and Combination), Application (Pediatrics and Adults), and End-user (Ambulatory Surgical Centers, Specialty Clinics, and Hospitals,)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

B. Braun SE;  DaVita Inc.; Medtronic;  Asahi Kasei Medical Co., Ltd.; Nipro Medical Corporation; Fresenius Medical Care AG & Co. KGaA; Merit Medical Systems; and Baxter.

Artificial Kidney Market Segment Insights

Device Type Segment Analysis

Based on device type, the artificial kidney market is divided into implantable artificial kidney and wearable artificial kidney. The wearable artificial kidney segment is anticipated to expand at a major growth rate during the projection period due to rising incidences of end-stage renal and kidney disorders.

Renal disease is a condition in which kidneys stop functioning and are unable to remove excess water and waste from the bloodstream. This disorder causes by high blood pressure, high blood sugar, blocked urinary tract, and chronic glomerulonephritis (kidney damage).

The wearable artificial organs designed for kidneys help to achieve the effective removal of toxins from the blood of patients with kidney failure. Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) are likely to be freed from fixed dialysis machines with wearable artificial kidney devices.

The implantable artificial kidney segment is expected to expand at a significant growth rate in the coming years due to offering improved quality of life and providing long-term solutions. Advancements in medical technology have made implantable artificial devices more advance and effective. This device leads to work more effectively and improves patient outcomes.

The implantable artificial kidney devices offer improved quality of life and reduce the need for external treatments such as dialysis and enhance patient’s mobility. Patients are looking for options that help them to regain their normal abilities and independence. The advantages of implantable artificial devices such as lower long-term healthcare costs and reduced hospital stays.

Artificial Kidney Market Device Type

Dialysis Segment Analysis

On the basis of dialysis, the global market is segregated into peritoneal dialysis, hemodialysis, and combination. Hemodialysis is projected to register a considerable CAGR during the forecast period due to the large number of procedures being performed. Hemodialysis is a process where a special filter and a dialysis machine called an artificial kidney, are used to clean blood.

Hemodialysis refers to the specific area focused on hemodialysis treatment, which is a common method of renal replacement therapy. Artificial kidney represents the devices, equipment, and technologies used in hemodialysis treatments. It addresses the needs of individuals with end-stage renal disease or other conditions requiring regular hemodialysis treatments.

The peritoneal dialysis segment is anticipated to hold a significant share of the market, due to convenience with flexibility and continuous treatments. Peritoneal dialysis is a type of renal replacement therapy that uses the peritoneal membrane in the abdomen to filter waste products and excess fluids from the blood. Peritoneal dialysis can be performed at home, which eliminates the need for frequent visits to a dialysis center.

 This provides patients with better independence and flexibility in managing their treatment. The ability to perform dialysis at home also reduces travel time and associated costs for patients, making it an attractive option. Peritoneal dialysis offers the advantage of continuous treatment throughout the day, in dissimilarity to hemodialysis, which is usually performed for a few hours, a few times a week.

Application Segment Analysis

On the basis of application, the artificial kidney market is segmented into pediatrics and adults. The adults segment is expected to register a robust growth rate during the forecast period due to the increasing prevalence of kidney disease among the adult population. Kidney disease is becoming more common in the adult population with factors including aging and chronic conditions such as diabetes and hypertension. Artificial kidneys offer a promising solution for individuals with end-stage renal disease (ESRD) or severe kidney failure. These devices can help to replace impaired kidney function and improve the quality of life for adult patients.

The pediatric segment is expected to hold a significant share of the market owing to focusing on specialized and customized treatment for pediatric patients. The specific area focused on the treatment of kidney-related conditions in pediatric patients.

Artificial kidney device addresses the unique needs and challenges faced by children with impaired kidney function, such as congenital renal disorders, kidney failure, or other renal diseases. Pediatric patients require specialized care and customized treatment methods due to their different physiological and developmental features.
 

Artificial Kidney Market Application

End user Segment Analysis

Based on the end-user, the artificial kidney market is segregated into ambulatory surgical centers, specialty clinics, and hospitals. The hospitals segment is expected to hold a significant market share during the assessment period due to the presence of skilled doctors and advanced healthcare infrastructure. Hospitals are the primary facilities for any surgical operations. A higher number of surgeries and transplantation of organs are performed in hospital settings as these hospitals have advanced facilities for the complete care of the patient before, during, and after the transplantation of the kidney.

The specialty clinics segment is projected to expand at a considerable growth rate during the projection period due to extensive and specialized treatment with expert professionals. Specialty hospitals are available for 24/7 emergency care with facilities such as ambulances, Intensive care units (ICUs), and emergency wards. They have dedicated operation theaters equipped with advanced patient monitoring equipment, anesthesia equipment, and surgical instruments.

Specialty clinics offer specialized expertise and dedicated care for individuals with kidney-related conditions. These clinics focus specifically on kidney diseases, allowing them to provide extensive and specialized treatment options to patients. They may have nephrologists, urologists, dialysis specialists, transplant surgeons, and other healthcare professionals working collaboratively to provide complete care for patients with kidney diseases.

Regional Outlook

In terms of region, the global artificial kidney market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to increasing research and development activities by research centers present in the region.

In North America, there are numerous popular research centers and institutions that are actively involved in studying and developing advanced medical technologies, including artificial kidneys. Research centers invest significant funding and resources into R&D for artificial kidneys. This allows them to carry out research, clinical trial, and innovation in the field of artificial kidneys.

The market in Europe is projected to grow rapidly during the forecast period, due to the presence of well-established healthcare infrastructure. In Europe, healthcare infrastructure includes advanced hospitals and medical centers that specialized in kidney care. These facilities have the necessary expertise and resources to support the development, manufacturing, and use of artificial kidneys.

This healthcare infrastructure ensures that patients with kidney diseases have access to high-quality care and advanced treatment options. It enables the increased availability and widespread adoption of artificial kidneys as a viable and effective treatment option for individuals experiencing impaired kidney function.

Artificial Kidney Market Region

Segments

The artificial kidney market has been segmented on the basis of

Device Type

  • Implantable Artificial Kidney
  • Wearable Artificial Kidney

Dialysis

  • Peritoneal Dialysis
  • Hemodialysis
  • Combination

Application

  • Pediatrics
  • Adults

End-user

  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Hospitals

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • B. Braun SE
  • DaVita Inc.
  • Medtronic
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Medical Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Merit Medical Systems
  • Baxter

Competitive Landscape

Key players competing in the artificial kidney market are B. Braun SE;  DaVita Inc.; Medtronic; Asahi Kasei Medical Co., Ltd.; Nipro Medical Corporation; Fresenius Medical Care AG & Co. KGaA; Merit Medical Systems; and Baxter.

These major players in the artificial kidney market are developing various strategies including mergers, acquisitions, partnerships, collaboration, and new product launches to expand their offerings, technological advancements, production expansion, and consumer base worldwide.

These companies are acknowledged for their substantial contributions to advancement in healthcare and have played a pivotal role in the research and development activities and commercialization of innovative technologies aimed at enhancing patient outcomes. For instance,

  • In April 2023, Medtronic and DaVita introduced Mozarc Medical, the aim is at launching new healthcare solutions for patients suffering from kidney failure. The purpose of launching new innovative kidney health technologies is to improve patients’ outcomes. With increasing preferences among patients and healthcare professionals toward in-home kidney care, Mozac Medical is positioned to serve high-quality services.
  • In September 2021, The US Kidney Research Corporation revealed the most recent technology that purifies the blood of individuals diagnosed with end-stage renal disease. This development involves miniaturized implantable artificial kidneys, which have the capability to provide real-time data.

Artificial Kidney Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Kidney Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Kidney Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Kidney Market - Supply Chain
  4.5. Global Artificial Kidney Market Forecast
     4.5.1. Artificial Kidney Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Kidney Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Kidney Market Absolute $ Opportunity
5. Global Artificial Kidney Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Artificial Kidney Market Size and Volume Forecast by Applications
     5.3.1. Pediatrics
     5.3.2. Adults
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Artificial Kidney Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Artificial Kidney Market Size and Volume Forecast by End Users
     6.3.1. Ambulatory Surgical Centers
     6.3.2. Specialty Clinics
     6.3.3. Hospitals
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Artificial Kidney Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Artificial Kidney Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Artificial Kidney Demand Share Forecast, 2019-2026
8. North America Artificial Kidney Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Artificial Kidney Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Artificial Kidney Market Size and Volume Forecast by Applications
     8.4.1. Pediatrics
     8.4.2. Adults
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Artificial Kidney Market Size and Volume Forecast by End Users
     8.7.1. Ambulatory Surgical Centers
     8.7.2. Specialty Clinics
     8.7.3. Hospitals
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Artificial Kidney Demand Share Forecast, 2019-2026
9. Latin America Artificial Kidney Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Artificial Kidney Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Artificial Kidney Market Size and Volume Forecast by Applications
     9.4.1. Pediatrics
     9.4.2. Adults
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Artificial Kidney Market Size and Volume Forecast by End Users
     9.7.1. Ambulatory Surgical Centers
     9.7.2. Specialty Clinics
     9.7.3. Hospitals
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Artificial Kidney Demand Share Forecast, 2019-2026
10. Europe Artificial Kidney Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Artificial Kidney Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Artificial Kidney Market Size and Volume Forecast by Applications
     10.4.1. Pediatrics
     10.4.2. Adults
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Artificial Kidney Market Size and Volume Forecast by End Users
     10.7.1. Ambulatory Surgical Centers
     10.7.2. Specialty Clinics
     10.7.3. Hospitals
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Artificial Kidney Demand Share Forecast, 2019-2026
11. Asia Pacific Artificial Kidney Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Artificial Kidney Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Artificial Kidney Market Size and Volume Forecast by Applications
     11.4.1. Pediatrics
     11.4.2. Adults
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Artificial Kidney Market Size and Volume Forecast by End Users
     11.7.1. Ambulatory Surgical Centers
     11.7.2. Specialty Clinics
     11.7.3. Hospitals
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Artificial Kidney Demand Share Forecast, 2019-2026
12. Middle East & Africa Artificial Kidney Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Artificial Kidney Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Artificial Kidney Market Size and Volume Forecast by Applications
     12.4.1. Pediatrics
     12.4.2. Adults
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Artificial Kidney Market Size and Volume Forecast by End Users
     12.7.1. Ambulatory Surgical Centers
     12.7.2. Specialty Clinics
     12.7.3. Hospitals
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Artificial Kidney Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Artificial Kidney Market: Market Share Analysis
  13.2. Artificial Kidney Distributors and Customers
  13.3. Artificial Kidney Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. B. Braun SE
     13.4.2. DaVita Inc.
     13.4.3. Medtronic
     13.4.4. Asahi Kasei Medical Co., Ltd.
     13.4.5. Nipro Medical Corporation
     13.4.6. Fresenius Medical Care AG & Co. KGaA
     13.4.7. Merit Medical Systems
     13.4.8. Baxter

Methodology

Our Clients

Honda Motor Co. Ltd.
Pfizer
General Mills
General Electric
FedEx Logistics
sinopec
Dassault Aviation
The John Holland Group